Menu
We love mRNA!
The BASE mRNA Facility was founded in 2021 with a mission to provide Australian scientists with rapid and reliable access to high-quality and affordable mRNA.
We help scientists build the next-generation of mRNA vaccines and therapies to treat disease.
The BASE facility is a non-profit facility supported by The University of Queensland (UQ) and Therapeutics Innovation Australia (TIA, NCRIS).
The BASE Research laboratories are located at the Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, St Lucia, Brisbane.
BASE laboratories include a team of production scientists with state-of-the-art equipment and expertise in the manufacture of mRNA for research use.
We have experience in the discovery and development of novel mRNA vaccines and therapies. We also lead research programs in advanced manufacturing, process development, and development of mRNA platform technologies.
The new BASE manufacture facilities opened at the Translational Research Institute (TRI) in 2024.
These state-of-art facilities support the production of mRNA and LNP at large scale, and are supported by detailed analysis to ensure mRNA quality.
Our expert scientists have experience building mRNA for a wide range of clinical applications, including vaccines, peptides and proteins, gene- and cell-therapies.
Research Laboratories
Level 3, AIBN (#75)
The University of Queensland
St Lucia, QLD 4072
Manufacture Facility
Level 6, Translational Research Institute
37 Kent St
Woolloongabba, QLD 4102